EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Gangliosides in Cutaneous Melanoma: Molecular Mechanisms, Translational Evidence Gaps, and Preclinical Natural-Compound Leads

Deog-Bon Koo iD, Kyongtae Kim, Juhwan Kim, Hyo Gyeong Yun, Eun Bin Song, Min Young Kim, Jae-Sung Ryu, Ji-Su Kim, Soyeon Kim, Hyun-A Lee, Young-Kug Choo

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27209021 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Deog-Bon Koo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, College of Engineering, Daegu University, 201 Deagudae-ro, Jillyang, Gyeongsan 38453, Gyeongbuk, Republic of Korea. Hauptthemen laut MEDLINE: Melanoma, Gangliosides, Skin Neoplasms, Biological Products. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wonkwang University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cutaneous melanoma remains lethal once metastatic despite advances in immune checkpoint blockade and BRAF/MEK-directed therapy. Gangliosides are surface-accessible sialylated glycosphingolipids that regulate membrane organization, adhesion, and signaling, representing potential biomarkers and therapeutic targets. This narrative review evaluated the translational readiness of ganglioside-directed strategies in cutaneous melanoma, without assuming that evidence from other GD2- or GD3-positive cancers is directly transferable. We synthesized melanoma-specific evidence on GD3-linked focal adhesion signaling, p130Cas/paxillin activity, PI3K–AKT and MAPK outputs, and distinct phenotypes associated with GD3, GD2, and GM3. We then applied an evidence-gated framework distinguishing melanoma clinical evidence, melanoma preclinical evidence, cross-tumor translational evidence, and hypothesis-generating claims. Direct contemporary clinical evidence in melanoma remains limited. Antibody, cellular, and biosynthetic enzyme strategies require diagnostic-quality antigen profiling, demonstration of surface accessibility and functional dependency, and prospective monitoring for antigen escape and neurotoxicity. Natural compounds, particularly quercetin, are mechanistic probes or formulation-enabled leads: a 2024 study reported reduced GM3/GD3 abundance and FAK/paxillin/AKT signaling in melanoma cell lines, but high in vitro concentrations and the lack of pharmacokinetic or in vivo validation preclude therapeutic conclusions. We proposed a minimum evidence package and go/no-go criteria for clinical translation, specifying experiments needed to advance ganglioside biology into biomarker-defined melanoma interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaGangliosidesSkin NeoplasmsBiological ProductsHumansAnimalsSignal TransductionCutaneous Malignant MelanomaPaxillinPhosphatidylinositol 3-Kinases

Stichwörter der Autor:innen

GD2GD3ST8SIA1cutaneous melanomafocal adhesion kinasegangliosideglycosphingolipidimmunotherapynatural productsquercetin

Substanzen

Gangliosidesganglioside, GD3Biological ProductsPaxillinPhosphatidylinositol 3-Kinases

Autor:innen und Institutionen

  • Department of Biotechnology, College of Engineering, Daegu University, 201 Deagudae-ro, Jillyang, Gyeongsan 38453, Gyeongbuk, Republic of Korea.
  • Department of Biological Science, College of Health Sciences, Wonkwang University, 460 Iksan-daero, Iksan-si 54538, Jeonbuk, Republic of Korea.
  • Division of Biodrug Evaluation, New Drug Development Center, Osong Medical Innovation Foundation (K-12 Bio Health), Cheongju 28160, Chungbuk, Republic of Korea.
  • Futuristic Animal Resource & Research Center, Korea Research Institute of Bioscience and Biotechnology, Cheongju 28116, Chungbuk, Republic of Korea.
  • Department of Companion Animal Industry, Wonkwang University, 460 Iksan-daero, Iksan-si 54538, Jeonbuk, Republic of Korea.
  • Center for Animal Resources Development, Wonkwang University, 460 Iksan-daero, Iksan-si 54538, Jeonbuk, Republic of Korea.

ORCID-Profile: Deog-Bon Koo

Förderung

  • Wonkwang University

Zitieren

APA

Koo, D. B., Kim, K., Kim, J., Yun, H. G., Song, E. B., Kim, M. Y., Ryu, J. S., Kim, J. S., Kim, S., Lee, H. A., & Choo, Y. K. (2026). Gangliosides in Cutaneous Melanoma: Molecular Mechanisms, Translational Evidence Gaps, and Preclinical Natural-Compound Leads. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27209021

Vancouver

Koo DB, Kim K, Kim J, Yun HG, Song EB, Kim MY, et al. Gangliosides in Cutaneous Melanoma: Molecular Mechanisms, Translational Evidence Gaps, and Preclinical Natural-Compound Leads. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27209021

BibTeX
@article{Koo2026,
  author = {Koo, Deog-Bon and Kim, Kyongtae and Kim, Juhwan and Yun, Hyo Gyeong and Song, Eun Bin and Kim, Min Young and Ryu, Jae-Sung and Kim, Ji-Su and Kim, Soyeon and Lee, Hyun-A and Choo, Young-Kug},
  title = {Gangliosides in Cutaneous Melanoma: Molecular Mechanisms, Translational Evidence Gaps, and Preclinical Natural-Compound Leads},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27209021}
}
Kostenlos starten →